Angiotensin II Trial NCT07921342 Registered, Not Yet Recruiting
A new trial involving angiotensin II, titled an individuation intervention for CKD care disparities, was listed as not yet recruiting on Nov 6, 2026.
Read Full ArticleAll News
Phase 3 Deucrictibant HAE Prophylaxis Trial Marked Completed
A Phase 3 trial of oral deucrictibant extended-release tablets for HAE angioedema attack prophylaxis was marked completed as of November 6, 2026.
Corticotropin Trial NCT06674499 Marked Completed as of Nov 2026
Trial update: "Support Intervention for Head and Neck Cancer Patients" study involving corticotropin is now listed as COMPLETED, per a Nov 6, 2026 record.
Glucagon-Related Trial "Slowly Digestible Carbohydrates for GLP-1 Secretion" Completed
Trial NCT07572513, studying slowly digestible carbohydrates for GLP-1 secretion, reached completed status as of Nov 6, 2026.
Phase 3 Trial of Once-Weekly SHR-3167 vs Insulin Glargine Registered
A Phase 3 trial comparing once-weekly SHR-3167 to once-daily insulin glargine in insulin-naive type 2 diabetes adults was posted, not yet recruiting.
Lanreotide Phase 3 Trial for Pancreatic Fistula Prevention Now Recruiting
A Phase 3 trial testing lanreotide versus placebo before surgery to prevent pancreatic fistula began recruiting, per a November 6, 2026 update.
Leptin Trial "Small Bowel Diversion" (NCT06374368) Terminated
A clinical trial studying leptin, titled "Small Bowel Diversion," has been listed as terminated per a ClinicalTrials.gov update dated Nov 6, 2026.
Trial Comparing Liraglutide to Sleeve Gastrectomy Now Recruiting
A new trial, NCT07901777, is recruiting as of Nov 6, 2026, comparing two-year weight loss with GLP-1 medications like liraglutide versus sleeve gastrectomy.
Trial Update: Phase 4 Study NCT05971732 Now Recruiting
A Phase 4 trial, COREVIVE-HFrEF, examining ferric derisomaltose in acute heart failure patients with iron deficiency is recruiting as of Nov 6, 2026.
Oxytocin Trial NCT06713473 on Self-Dehumanization, Suicide Risk Withdrawn
A trial studying oxytocin and self-dehumanization related to suicide risk, NCT06713473, is listed as withdrawn as of November 6, 2026.
Semaglutide Phase 2 Trial on Aging and Healthspan Not Yet Recruiting
A Phase 2 trial, NCT07923630, testing semaglutide for aging, longevity and healthspan validation was listed on Nov 6, 2026, status not yet recruiting.
Trial Update: Substance P Studied in Post-Operative Endodontic Pain Trial
A trial examining cryotherapeutic and nanotherapeutic sodium hypochlorite for post-operative endodontic pain, involving substance P, is now recruiting as of Nov 6, 2026.
Terlipressin Study Listed: DPMAS-ACLF Trial Not Yet Recruiting
A new trial involving terlipressin, the DPMAS-ACLF study on acute-on-chronic liver failure, was registered on Nov 6, 2026, status not yet recruiting.
Phase 4 Trial Update: Thymosin Alpha 1 and IgM in Sepsis
A Phase 4 trial, "Thymosin Alpha 1 and IgM Levels in Sepsis," is now active but not recruiting, per a November 6, 2026 update.
Phase 3 Trial of CagriSema for Hypertension in Obesity Not Yet Recruiting
A new Phase 3 trial, NCT07919405, will study CagriSema for lowering high blood pressure in people with obesity. Status: not yet recruiting as of Nov 5, 2026.
Goserelin-Linked Phase 2 Trial of Darolutamide Plus ADT Now Recruiting
A Phase 2 trial testing darolutamide with ADT, which may include goserelin, before prostate surgery began recruiting as of Nov 5, 2026.
Phase 1 Trial Registered Comparing GZR101-80 With Insulin Aspart Combo
A Phase 1 trial (NCT07918898) comparing GZR101-80 injection to separate GZR33 and insulin aspart doses was registered, not yet recruiting as of Nov 5, 2026.
Phase 2 Trial on 68-Ga-DOTATATE PET/CT for Thyroid Cancer Updated
A Phase 2 trial (NCT04927416) studying 68-Gallium-DOTATATE-PET/CT imaging in metastatic thyroid cancer was updated November 5, 2026; status is recruiting.
Thymosin Beta-4 Trial SEER-2 (NCT05555589) Marked Completed
A Phase 3 trial of 0.1% RGN-259 ophthalmic solution, containing thymosin beta-4, for neurotrophic keratopathy was listed as completed on Nov 5, 2026.
Phase 3 Trial Recruiting for Monthly Berobenatide in Weight Maintenance
A Phase 3 trial is recruiting participants to study switching to monthly berobenatide (PF-08653944) for weight maintenance, per a November 2026 listing.
Trial on Smart Water Bottle Intervention Tied to Vasopressin Completed
A trial titled "Efficacy of a Smart Water Bottle Intervention to Increase Fluid Consumption in College Students" has reached completed status as of Nov 5, 2026.